2.7800
-0.2300
(-7.64%)
At close: January 10 at 4:00:02 PM EST
2.8300
+0.05
+(1.80%)
After hours: 7:40:42 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-99,140.0000
-67,999.0000
-96,108.0000
-68,190.0000
-36,529.0000
Investing Cash Flow
104,094.0000
8,921.0000
63,457.0000
-454,669.0000
-70,320.0000
Financing Cash Flow
1,351.0000
628.0000
1,327.0000
625,527.0000
133,135.0000
End Cash Position
30,700.0000
42,649.0000
101,099.0000
132,423.0000
29,755.0000
Capital Expenditure
-188.0000
-69.0000
-370.0000
-282.0000
-145.0000
Issuance of Capital Stock
--
--
--
--
135,657.0000
Free Cash Flow
-99,328.0000
-68,068.0000
-96,478.0000
-68,472.0000
-36,674.0000
12/31/2020 - 8/26/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VOR Vor Biopharma Inc.
1.5550
-4.60%
SWTX SpringWorks Therapeutics, Inc.
43.00
+6.20%
VTYX Ventyx Biosciences, Inc.
2.0800
-7.56%
IPSC Century Therapeutics, Inc.
0.9900
-7.48%
LYEL Lyell Immunopharma, Inc.
0.6040
-7.32%
TSHA Taysha Gene Therapies, Inc.
1.7600
-8.81%
RLAY Relay Therapeutics, Inc.
4.4500
-7.87%
CMPX Compass Therapeutics, Inc.
1.7700
-4.84%
IDYA IDEAYA Biosciences, Inc.
24.03
-3.30%
STOK Stoke Therapeutics, Inc.
9.00
+0.45%